Kidney volume and function in autosomal dominant polycystic kidney disease

[1]  E. J. van der Jagt,et al.  Early renal abnormalities in autosomal dominant polycystic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[2]  Douglas Landsittel,et al.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[3]  L. Antiga,et al.  Sirolimus therapy to halt the progression of ADPKD. , 2010, Journal of the American Society of Nephrology : JASN.

[4]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  J. Stockman,et al.  Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease , 2012 .

[6]  Oliver Senn,et al.  Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. , 2010, The New England journal of medicine.

[7]  Ajay V. Srivastava,et al.  Autosomal dominant polycystic kidney disease. , 2014, American family physician.

[8]  Oliver Senn,et al.  Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. , 2009, Kidney international.

[9]  Diego R. Martín,et al.  Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[10]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Paul A Thompson,et al.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. , 2003, Kidney international.

[12]  Paul A Thompson,et al.  Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[13]  P K Commean,et al.  Volumetric Measurement of Renal Cysts and Parenchyma Using MRI: Phantoms and Patients with Polycystic Kidney Disease , 2000, Journal of computer assisted tomography.

[14]  Homer W. Smith.  Nephron adaptation to renal injury or ablation , 2003 .

[15]  T. Mochizuki,et al.  Renal disease progression in autosomal dominant polycystic kidney disease , 2012, Clinical and Experimental Nephrology.

[16]  F. Reubi,et al.  Rate of functional deterioration in polycystic kidney disease. , 1983, Kidney international.

[17]  A. Tamakoshi,et al.  Prevalence and Renal Prognosis of Diagnosed Autosomal Dominant Polycystic Kidney Disease in Japan , 1998, Nephron.

[18]  G. Brosnahan,et al.  Volume progression in polycystic kidney disease. , 2006, The New England journal of medicine.

[19]  A. Chapman,et al.  Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[20]  G. Filler,et al.  Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  A. Rule,et al.  Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. , 2006, Journal of the American Society of Nephrology : JASN.

[22]  R. Schrier,et al.  Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[23]  J. Felmlee,et al.  Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. , 2006, Clinical journal of the American Society of Nephrology : CJASN.